You're contacting media contact of this press release

Title: FIPMed is Expanding Access to Life-Saving FIP Treatments Worldwide

FIP has claimed the lives of many cats worldwide. Thanks to recent developments, the disease is now curable, and FIPMed is helping a global customer base get access to this groundbreaking treatment.United States, 19th Aug 2024 - Losing their beloved pet to disease is the worst nightmare for many owners. For years, Feline Infectious Peritonitis (FIP) has been a common cause of that nightmare becoming a reality, as the disease has a high mortality rate and used to be very difficult to treat. Recent strides and new medications have worked to greatly reduce the mortality rate of FIP, however, and FIPMed is working hard to help more cat owners around the world get access to the life-saving treatment.FIPMed is a pharmaceutical company that specializes in selling cat FIP treatments. The company's mission centers around the development and distribution of effective treatments that combat this serious illness, providing hope and solutions to cat owners and veterinary professionals worldwide. Today, FIPMed delivers its treatment solutions to over 150 countries worldwide, delivering medications in as little as 1 day to pet owners in need.The company operates from the premise that timely and targeted medical intervention can significantly enhance the survival rates of cats afflicted with FIP. That's why they put such a strong emphasis on a short delivery time and 24/7 support with their chatbot Clawdia. Pet parents in need can visit the FIPMed website and get immediate assistance from the company's chatbot assistant, or email the company and receive a response within 2 hours.FIPMed has developed a range of pharmaceutical products that are based on the antiviral compound GS-441524, a substance closely related to the human drug Remdesivir, which was initially developed by Gilead...

This press release is issued by King Newswire